Tag: CBT > Tilray Cannabis Company

Canadian Cannabis Market

Tilray Expands Canadian Cannabis Portfolio With Launch of PORTAL

The cannabis company’s new high-intensity brand is for experienced consumers.

April 8, 2026

International

Tilray Medical Expands Medical Cannabis Portfolio in Australia

The company’s largest expansion in Australia to date includes new products across multiple formats under its Redecan and Good Supply brands.

March 19, 2026

International

Tilray Medical, CC Pharma, 14U Pharma Announce Strategic Alliance With ‘gesund leben’ Cooperation, Alliance Healthcare Deutschland

The alliance will accelerate market expansion and strengthen pharmacy access across Germany.

March 12, 2026

International

Tilray Brands Acquires BrewDog Australia

The acquisition sets up the cannabis company to accelerate its global beverage and consumer products growth across the Asia-Pacific Region.

March 9, 2026

International

Tilray Expands UK Pharmaceutical Access Through Strategic Agreement With Smartway Pharmaceuticals

The company’s CC Pharma agreement is expected to embed Tilray into the U.K. health system for its own medicinal cannabis products.

February 12, 2026

International

Tilray Medical Strengthens Italian Market Presence

The company launched Tilray Medical Italia, expanding its medical cannabis portfolio in the country.

January 22, 2026

Finance

Tilray Brands Delivers Record Quarterly Net Revenue of $218M

The cannabis company moved to net cash positive and reaffirmed its full-year adjusted EBITDA guidance.

January 9, 2026

Canadian Cannabis Market

Tilray Unveils Good Supply Vapes in Quebec

The company’s provincial launch follows the recent introduction of vape products in Quebec.

November 24, 2025

International

Tilray Medical Enters Joint Venture to Expand Cannabis Operations Into Panama

The company’s joint venture with Top Tech Global includes a medical cannabis license issued by the National Directorate of Pharmacy and Drugs.

October 14, 2025

Medical Cannabis Access and Pricing

Tilray Medical Expands Presence in Germany

The cannabis company introduced new Good Supply strains, affirming its commitment to German health care and expanding patient and pharmacy access.

August 28, 2025

Finance

Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance

The Canadian cannabis company requested an extension to meet Nasdaq listing requirements as it considers a reverse stock split.

August 14, 2025

International

Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Cannabis Extracts

Tilray’s FL Group teamed up with Molteni, a major pharmaceutical firm focused on pain and substance dependence therapies.

August 13, 2025